Multimodal Prehabilitation and Rehabilitation for Men Undergoing Robot-Assisted Radical Prostatectomy
NCT07576335 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2026-05-08
Summary
Prostate cancer is the most common cancer in Australian men. Robot-assisted radical prostatectomy (RARP) - surgical removal of the prostate - is a standard treatment, but it frequently causes erectile dysfunction (ED) and urinary incontinence that can persist for years and significantly affect quality of life.
This trial (ROBOPREP) will test whether a multimodal program of prehabilitation (before surgery) and rehabilitation (after surgery) improves erectile function and urinary continence in men undergoing RARP, compared to standard care alone.
The program includes four components, all delivered virtually and in a self-directed manner:
1. Pharmacological - tadalafil 5 mg once daily (a low-dose, TGA-approved erectile medication) beginning 4 weeks before surgery, paused during hospital admission, and resumed for 3 months following catheter removal after surgery.
2. Exercise - pelvic floor muscle training (3 sets per day) and aerobic exercise (40 minutes, 4 times per week) to strengthen the muscles and vascular supply involved in erectile and urinary function.
3. Nutrition - dietary guidance to support surgical recovery and vascular health.
4. Psychological/wellbeing - relaxation techniques, psychoeducation about expected recovery, and self-compassion strategies to address cancer-related anxiety.
A total of 64 men will be recruited across three major Sydney hospitals (Royal Prince Alfred Hospital, Concord Repatriation General Hospital, and Chris O'Brien Lifehouse) and randomly assigned 1:1 to the multimodal program plus standard care, or to standard care alone. Outcomes - including erectile function (primary), urinary continence, quality of life, and psychological wellbeing - are assessed at baseline and at 6 weeks, 3, 6, and 12 months following surgery. All participant-facing elements of the program are digital, low-cost, and designed for real-world scalability.
Conditions
- Erectile Dysfunction Following Radical Prostatectomy
- Prostate Cancer
- Urinary Incontinence Following Surgical Procedure
Interventions
- DRUG
-
Tadalafil 5 mg
Tadalafil 5 mg tablet, taken orally once daily. Commenced 4 weeks prior to surgery, ceased during hospital admission (3 days prior to surgery), and recommenced following postoperative urinary catheter removal (typically 5-10 days post-surgery) for 3 months. Total intended duration approximately 4 months. Supplied via standard prescription dispensing at community pharmacies (Generic Health brand). Reimbursement provided to participants via a cash card. TGA ARTG number: 289541.
- BEHAVIORAL
-
Pelvic Floor Muscle Training (PFMT)
Self-directed PFMT performed 3 sets per day. Each set comprises 20 fast contractions (1-second duration) and 20 slow contractions (10 seconds on, 10 seconds off). Adapted from Milios et al. (2020) using Continence Australia guidelines. Delivered via co-designed digital booklet and avatar instructional videos. Commenced 4 weeks preoperatively, continuing through 3 months postoperatively.
- BEHAVIORAL
-
Aerobic Exercise Program
Self-directed aerobic exercise at moderate-to-vigorous intensity (e.g., brisk walking while able to maintain conversation), 40 minutes per session, 4 sessions per week. Dose established by Gerbild et al. (2018). Delivered via digital booklet and avatar videos. Commenced 4 weeks preoperatively, continuing through 3 months postoperatively.
- BEHAVIORAL
-
Nutritional Recommendations
Structured dietary guidance addressing protein intake, fruit and vegetable consumption, wholegrains, healthy fats, hydration, and blood sugar control. Designed by a dietitian to support surgical healing, vascular health, and erectile and urinary function recovery. Delivered via digital booklet and avatar videos. Commenced 4 weeks preoperatively, continuing through 3 months postoperatively.
- BEHAVIORAL
-
Psychological and Wellbeing Strategies
Self-directed psychological wellbeing program comprising: (1) relaxation techniques (progressive muscle relaxation, diaphragmatic/rectangle breathing, mindfulness/grounding); (2) psychoeducation on psychogenic erectile dysfunction, expected postoperative complications (ED, UI); (3) self-compassion and cognitive reframing strategies; (4) motivational interviewing-style elements to support adherence; (5) advice on social connection, smoking cessation, alcohol reduction, and sleep hygiene. Designed by a clinical psychologist and delivered via digital booklet and videos. Commenced 4 weeks preoperatively, continuing through 3 months postoperatively.
- BEHAVIORAL
-
Standard Perioperative Care
Usual high-standard pre- and postoperative care delivered by the treating urological team, including clinical advice on exercise, nutrition, smoking cessation, alcohol reduction, expected surgical sequelae, pelvic floor exercises, blood sugar optimisation, medication review, and anaemia screening. Includes prostate cancer nurse specialist consultations and urology clinic follow-up.
Sponsors & Collaborators
-
Generic Health
collaborator UNKNOWN -
National Health and Medical Research Council, Australia
collaborator OTHER -
Sydney Local Health District
collaborator OTHER_GOV -
Surgical Outcomes Research Centre (SOuRCe)
lead NETWORK
Principal Investigators
-
Daniel Steffens · Surgical Outcomes Research Centre (SOuRCe)
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-01
- Primary Completion
- 2028-02-01
- Completion
- 2028-11-01
Countries
- Australia
Study Locations
More Related Trials
-
A Study of Effects of Fesoterodine in Men at High Risk for Overactive Bladder/Detrusor Overactivity Post Robotic-Assisted Lap. Prostatectomy
NCT01661166 ·Status: COMPLETED ·Phase: PHASE4
-
Low-Intensity Extracorporeal Shockwave Therapy for Penile Rehabilitation in Post-Radical Prostatectomy Patients
NCT06076850 ·Status: RECRUITING ·Phase: NA
-
Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy
NCT07101731 ·Status: RECRUITING ·Phase: NA
-
Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy
NCT04638088 ·Status: RECRUITING
-
Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling
NCT00937833 ·Status: COMPLETED ·Phase: NA
-
Impact of Tamsulosin on Voiding Patterns Following Early Catheter Removal After Robot-assisted Laparoscopic Radical Prostatectomy
NCT01209988 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
NCT05537272 ·Status: UNKNOWN ·Phase: PHASE4
-
EFFICACY of INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION on the POSTOPERATIVE BLOOD LOSS in PATIENTS UNDERGOING RARP for the TREATMENT of PROSTATE CANCER
NCT06822036 ·Status: RECRUITING ·Phase: NA
-
Tadalafil Daily Used Post Turp
NCT06788704 ·Status: COMPLETED
-
The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy
NCT04577222 ·Status: UNKNOWN ·Phase: NA
-
Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy
NCT03061760 ·Status: UNKNOWN
-
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
NCT02352103 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating Return to Continence and Potency Following Radical Prostatectomy
NCT05742334 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of RestoreX Penile Traction Therapy In Preserving Erectile Function Post-Prostatectomy
NCT05244486 ·Status: RECRUITING ·Phase: NA
-
Prospective RCT on Post Prostatectomy Urine Leak
NCT02367404 ·Status: UNKNOWN ·Phase: PHASE3
-
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES)
NCT07427043 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of New Posterior Reconstruction Method on Recovery of Continence After Robot-assisted Laparoscopic Prostatectomy
NCT01714219 ·Status: COMPLETED ·Phase: NA
-
Data Collection Post Radical Prostatectomy
NCT06351579 ·Status: COMPLETED
-
Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy
NCT00956904 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Herbal Supplement Prosta-OK® Neo as an Adjunct Therapy in Patients With Mild to Severe Non-neurogenic Male Lower Urinary Tract Symptoms Receiving Tamsulosin Therapy
NCT04418635 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Immediate Urinary Continence Predictors After RS-RARP
NCT06850116 ·Status: ACTIVE_NOT_RECRUITING
-
Trial to Compare Urinary Continence Recovery After Robotic Radical Prostatectomy With or Without Rhabdosphincter Reconstruction.
NCT03302169 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Nerve Monitoring During Robot-assisted Laparoscopic Prostatectomy
NCT02446808 ·Status: UNKNOWN ·Phase: NA
-
Study of Light-Activated Talaporfin Sodium in Patients With Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
NCT00918034 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate
NCT05766163 ·Status: UNKNOWN ·Phase: NA